199 related articles for article (PubMed ID: 31463653)
21. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
22. Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer.
Schnurr M; Duewell P
Oncoimmunology; 2014 Oct; 3(9):e955687. PubMed ID: 25941620
[TBL] [Abstract][Full Text] [Related]
23. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
[TBL] [Abstract][Full Text] [Related]
24. A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells.
Liu J; Guo YM; Hirokawa M; Iwamoto K; Ubukawa K; Michishita Y; Fujishima N; Tagawa H; Takahashi N; Xiao W; Yamashita J; Ohteki T; Sawada K
Exp Hematol; 2012 Apr; 40(4):330-41. PubMed ID: 22198151
[TBL] [Abstract][Full Text] [Related]
25. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells.
Colangelo T; Polcaro G; Ziccardi P; Muccillo L; Galgani M; Pucci B; Milone MR; Budillon A; Santopaolo M; Mazzoccoli G; Matarese G; Sabatino L; Colantuoni V
Cell Death Dis; 2016 Feb; 7(2):e2108. PubMed ID: 26913599
[TBL] [Abstract][Full Text] [Related]
26. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
27. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
[TBL] [Abstract][Full Text] [Related]
28. Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells.
Kübler K; Gehrke N; Riemann S; Böhnert V; Zillinger T; Hartmann E; Pölcher M; Rudlowski C; Kuhn W; Hartmann G; Barchet W
Cancer Res; 2010 Jul; 70(13):5293-304. PubMed ID: 20551064
[TBL] [Abstract][Full Text] [Related]
29. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
30. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
31. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
32. Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation.
Cerqueira OLD; Clavijo-Salomon MA; Cardoso EC; Citrangulo Tortelli Junior T; Mendonça SA; Barbuto JAM; Strauss BE
Front Immunol; 2020; 11():576658. PubMed ID: 33193370
[TBL] [Abstract][Full Text] [Related]
33. The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity.
Girone C; Calati F; Lo Cigno I; Salvi V; Tassinari V; Schioppa T; Borgogna C; Lospinoso Severini L; Hiscott J; Cerboni C; Soriani A; Bosisio D; Gariglio M
Cancer Immunol Immunother; 2023 Sep; 72(9):3097-3110. PubMed ID: 37356050
[TBL] [Abstract][Full Text] [Related]
34. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2.
Mhaidat NM; Wang Y; Kiejda KA; Zhang XD; Hersey P
Mol Cancer Ther; 2007 Feb; 6(2):752-61. PubMed ID: 17308071
[TBL] [Abstract][Full Text] [Related]
36. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.
Angelova AL; Grekova SP; Heller A; Kuhlmann O; Soyka E; Giese T; Aprahamian M; Bour G; Rüffer S; Cziepluch C; Daeffler L; Rommelaere J; Werner J; Raykov Z; Giese NA
J Virol; 2014 May; 88(10):5263-76. PubMed ID: 24574398
[TBL] [Abstract][Full Text] [Related]
37. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
38. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
[TBL] [Abstract][Full Text] [Related]
39. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
[TBL] [Abstract][Full Text] [Related]
40. Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro.
Montico B; Nigro A; Lamberti MJ; Martorelli D; Mastorci K; Ravo M; Giurato G; Steffan A; Dolcetti R; Casolaro V; Dal Col J
Cytotherapy; 2024 Feb; 26(2):145-156. PubMed ID: 38099895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
